Dendreon Corporation Announces Presentation of PROVENGE® Sipuleucel-T

Dendreon Corporation Announces Presentation of PROVENGE® sipuleucel-T

Filed under: Centers

Additionally, preliminary data from an ongoing open-label study of PROVENGE treatment in men with mCRPC who were previously treated with PROVENGE in the androgen dependent prostate cancer (ADPC) setting suggest long-lived immunological memory to …
Read more on HispanicBusiness.com

 

Colorado mom treats son's cancer with medical marijuana

Filed under: Oregon Drug Treatment Centers

Doctors in their hometown of Salt Lake City began the standard treatment of radiation and chemotherapy, which took a heavy toll on his little body. Landon became … Last year, a 7-year-old girl in Oregon was given the drug by her mother to ease …
Read more on New York Daily News

 

No High-Quality Studies for Cushing's Drugs

Filed under: Oregon Drug Treatment Centers

The review of the literature evaluating drug treatments for Cushing's disease, a rare pituitary disorder, is the first to employ a rigorous systematic approach with strict, predefined inclusion criteria and formal analysis of the quality of evidence …
Read more on MedPage Today

 

Coast battles teen alcohol, drug abuse

Filed under: Oregon Drug Treatment Centers

“Last year our main focus was the student-based health center,” said Schacher. “However … “We have excellent treatment professionals who are doing evidence-based programs that work, but in Oregon we don't have enough treatment and we need more.”.
Read more on Daily Astorian

 


Tags: , ,

Leave a Reply

Your email address will not be published. Required fields are marked *